PlainPharmaWatch

CMS Open Payments · Tool

Kyocera Medical Technologies, Inc. vs BeiGene Switzerland GmbH

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

BeiGene Switzerland GmbH has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 5,399, versus 480 for the other company. Its single largest recorded recipient represents 0.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Kyocera Medical Technologies, Inc.
HHI 480 · top recipient 0.1%
Ranked #1,304 of 1,838 companies by HHI
BeiGene Switzerland GmbH
HHI 5,399 · top recipient 0.7%
Ranked #306 of 1,838 companies by HHI

Payment Overview

Total Payments
$799.3K
% of Industry
0.0%
Transactions
344
Avg per Transaction
$2.3K
Recipients
340
Avg per Recipient
$2.4K
Payment Types
4
Top Payment Type
Consulting Fee
Total Payments
$799.5K
% of Industry
0.0%
Transactions
33
Avg per Transaction
$24.2K
Recipients
25
Avg per Recipient
$32.0K
Payment Types
4
Top Payment Type
Grant

Highlighted values indicate the higher figure for each metric.

Total payments compared

Kyocera Medical Technologies, Inc. vs BeiGene Switzerland GmbH - total reported payments in CMS Open Payments PY2024

BeiGene Switzerland GmbH$799.5KKyocera Medical Technologie…$799.3K

Payment Types Breakdown

Kyocera Medical Technologies, Inc.

Consulting Fee $400.4K

50.1%

Royalty or License $249.4K

31.2%

Travel and Lodging $21.3K

2.7%

Food and Beverage $18.6K

2.3%

BeiGene Switzerland GmbH

Grant $100.0K

12.5%

Consulting Fee $22.9K

2.9%

Travel and Lodging $17.5K

2.2%

Food and Beverage $253.36

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Kyocera Medical Technologies, Inc.

  1. 1

    SEAN JONES-QUAIDOO

    $75,951.68 · 12 txns

  2. 2

    NEVILLE ALLEYNE

    $69,829.14 · 3 txns

  3. 3

    JOHN STEINMANN

    $51,229.43 · 2 txns

  4. 4

    PAYAM MOAZZAZ

    $41,614.78 · 2 txns

  5. 5

    IAN COTE

    $34,165.43 · 16 txns

BeiGene Switzerland GmbH

  1. 1

    Dana-Farber Cancer Institute

    $100,000.00 · 1 txns

  2. 2

    MATTHEW S DAVIDS

    $24,540.17 · 6 txns

  3. 3

    STEVEN P TREON

    $6,345.56 · 5 txns

  4. 4

    JORGE J CASTILLO

    $4,095.56 · 5 txns

  5. 5

    MARIA LIA PALOMBA

    $3,799.09 · 3 txns

Summary Comparison

Metric Kyocera Medical Technologies, Inc. BeiGene Switzerland GmbH
Total Payments $799.3K $799.5K
% of Industry Total 0.0% 0.0%
Transaction Count 344 33
Avg per Transaction $2.3K $24.2K
Recipient Count 340 25
Avg per Recipient $2.4K $32.0K
Payment Type Count 4 4
Top Payment Type Consulting Fee Grant

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.